The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)

被引：60
|
作者：
Gil-Prieto, Ruth [1 ]
Garcia-Garcia, Laura [1 ]
Alvaro-Meca, Alejandro [1 ]
Mendez, Cristina [2 ]
Garcia, Ana [2 ]
Gil de Miguel, Angel [1 ]
机构：
[1] Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth & Med Immunol & Micr, Madrid 28922, Alcorcon, Spain
[2] Pfizer, Dept Med, Madrid, Spain
来源：
VACCINE | 2011年 / 29卷 / 03期
关键词：
Hospitalisations; Pneumococcal pneumonia; CAP; POPULATION; EPIDEMIOLOGY; OLDER;
D O I：
10.1016/j.vaccine.2010.11.025
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
All hospital discharges and deaths related to CAP and pneumococcal-pneumonia from adults over 50 from 2003 to 2007 in Spain were obtained. Among the 447,670 Pneumonia-all causes discharges 17% were pneumococcal pneumonia. The annual hospitalisation rate was 6.27 and 1.09 cases per 1000, respectively. 75,932 deaths for Pneumonia-all causes and 9062 for pneumococcal-pneumonia were reported. CAP and pneumococcal pneumonia are major causes of morbidity and mortality in Spain, especially in the elderly. Despite current preventive measures, no significant changes in hospitalisation, mortality and case-fatality rates were found over the study period. Future preventive measures, like vaccination, could overcome these limitations. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：412 / 416
页数：5
相关论文
共 50 条
  • [41] BURDEN OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS OVER 18 YEARS OF AGE
    Cuhadaroglu, C.
    Alici, D. E.
    Hacibedel, B.
    Saribas, G.
    Kosar, F.
    VALUE IN HEALTH, 2015, 18 (07) : A497 - A498
  • [42] Clinical and economic burden of community-acquired pneumonia among adults in Europe
    Welte, T.
    Torres, A.
    Nathwani, D.
    THORAX, 2012, 67 (01) : 71 - 79
  • [43] Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
    Marcos, MA
    de Anta, MTJ
    de la Bellacasa, JP
    González, J
    Martínez, E
    García, E
    Mensa, J
    de Roux, A
    Torres, A
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) : 209 - 214
  • [44] Antibiotic strategy in severe community-acquired pneumococcal pneumonia
    Le Bris-Tomczak, A.
    Bedos, J-P
    Billon, C.
    Samdjee, F.
    Le Monnier, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (05): : 226 - 234
  • [45] Optimal therapy for severe pneumococcal community-acquired pneumonia
    Manel Luján
    Miguel Gallego
    Jordi Rello
    Intensive Care Medicine, 2006, 32 : 971 - 980
  • [46] Decrease in drug resistance in pneumococcal community-acquired pneumonia
    Obando, Ignacio
    Arroyo, Luis
    Sanchez-Tatay, David
    CHEST, 2007, 132 (01) : 359 - 359
  • [47] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Endimiani, A
    Brigante, G
    Bettaccini, AA
    Luzzaro, F
    Grossi, P
    Toniolo, AQ
    BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [48] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Andrea Endimiani
    Gioconda Brigante
    Alessia A Bettaccini
    Francesco Luzzaro
    Paolo Grossi
    Antonio Q Toniolo
    BMC Infectious Diseases, 5
  • [49] Pneumococcal diagnosis and serotypes in childhood community-acquired pneumonia
    Elemraid, Mohamed A.
    Sails, Andrew D.
    Thomas, Matthew F.
    Rushton, Stephen P.
    Perry, John D.
    Eltringham, Gary J. A.
    Spencer, David A.
    Eastham, Katherine M.
    Hampton, Fiona
    Gennery, Andrew R.
    Clark, Julia E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (02) : 129 - 132
  • [50] Optimal therapy for severe pneumococcal community-acquired pneumonia
    Lujan, Manel
    Gallego, Miguel
    Rello, Jordi
    INTENSIVE CARE MEDICINE, 2006, 32 (07) : 971 - 980
12345